PCaP Acknowledgment Statements

INCLUDE THE RELEVANT AND/OR COMBINATION OF RELEVANT ACKNOWLEDGEMENTS IN MANUSCRIPTS UTILIZING PCAP OR PCAP FOLLOW UP DATA

For all baseline - only studies

The North Carolina-Louisiana Prostate Cancer Project (PCaP) is carried out as a collaborative study supported by the Department of Defense contract DAMD 17-03-2-0052. The authors thank the staff, advisory committees and research subjects participating in the PCaP study for their important contributions.

IN ADDITION, PLEASE INCLUDE THE FOLLOWING IF APPLICABLE

For studies involving tissue specimens

We would like to acknowledge the RPCI Department of Urology Tissue Microarray and Immunoanalysis Core for our tissue processing, storage and sample disbursement.

 

For studies involving other specimens

We would like to acknowledge the UNC BioSpecimen Facility and the LSUHSC Pathology Lab for our DNA extractions, blood processing, storage and sample disbursement (https://genome.unc.edu/bsp). Link: https://genome.unc.edu/bsp

 

For all combined (PCaP) baseline and NC 4-year follow-up study, HCaP-NC

The North Carolina-Louisiana Prostate Cancer Project (PCaP) and the Health Care Access and Prostate Cancer Treatment in North Carolina (HCaP-NC) study are carried out as collaborative studies supported by the Department of Defense contract DAMD 17-03-2-0052 and the American Cancer Society award RSGT-08-008-01-CPHPS, respectively. The authors thank the staff, advisory committees and research subjects participating in the PCaP and HCaP-NC studies for their important contributions.

 

For all NC 4-year follow-up study, HCaP-NC only

The Health Care Access and Prostate Cancer Treatment in North Carolina (HCaP-NC) study is carried out as a collaborative study supported by the American Cancer Society award RSGT-08-008-01-CPHPS. The authors thank the staff, advisory committees and research subjects participating in the HCaP-NC study for their important contributions.

 

For all 10-year follow-up study, PCaP FT only

Racial Differences in Financial Impact of Prostate Cancer Treatment and Outcome (PCaP FT) is carried out as a collaborative study supported by the Department of Defense contract DAMD W81XWH-17-1-0119. The authors thank the staff, advisory committees and research subjects participating in the PCaP study for their important contributions.

 

For all studies using CIPHR Claims Data

NOTE: All manuscripts using CIPHR claims data must be submitted to CIPHR for manuscript review. You do NOT have to wait for their approval before submitting to a journal. Work on this study was supported by the Cancer Information and Population Health Resource, UNC Lineberger Comprehensive Cancer Center, with funding provided by the University Cancer Research Fund via the state of North Carolina.